Riskpilot← Back to searchSign inGet full accessDOMORE DIAGNOSTICS AS
ASActiveOrg 925769681Ullernchausséen 64, 0379 OsloComputer programming activities · NACE 6210Est. 20209 employees
Revenue 2024
NOK 0
EBITDA margin
—
+95% vs 2023
Equity ratio
70.1%
Financial strength
Net profit 2024
NOK -93K
+97% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -168K | +95% |
| Net profit | NOK -93K | +97% |
| Total assets | NOK 31,4M | +132% |
| Equity | NOK 22M | +1404% |
| Employees | 9 | — |
Legal name
DOMORE DIAGNOSTICS AS
Org number
925769681
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
23. oktober 2020
Share capital
NOK 56 778
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utvikling og salg av systemer for dataanalyse av medisinske bilder.
Address
Ullernchausséen 64, 0379 Oslo
Email
torbjorn.furuseth@domorediagnostics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 75 | 0 |
| Staff expenses | −0 | −875 | −5 629 | −1 623 | −2 362 |
| EBITDA | 0 | −1 759 | −8 352 | −3 423 | −168 |
| Depreciation & amort. | −0 | −0 | −8 | −26 | −850 |
| EBIT | 0 | −1 759 | −8 360 | −3 450 | −1 018 |
| Net financials | 0 | −1 | −20 | 24 | 925 |
| Profit before tax | 0 | −1 760 | −8 379 | −3 425 | −93 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −1 760 | −8 379 | −3 425 | −93 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 24 | 13 314 | 6 539 | 13 530 | 31 381 |
| Equity | 24 | 8 267 | 4 887 | 1 462 | 21 989 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 5 048 | 1 652 | 12 068 | 9 392 |
| Total debt | 0 | 5 048 | 1 652 | 12 068 | 9 392 |
EBITDA margin
-16751300.0%
This company
15.8%
Market median
-106020986% vs market
20202024
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
20202024
Net profit margin
-9253200.0%
This company
8.1%
Market median
-114237137% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-09-17 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TF Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Norselab F I Dom As | Company | 28.1% | 28.1% | 2024 |
| Individual | 14.2% | 14.2% | 2022 | |
Grotmol Solutions As | Company | 8.6% | 8.6% | 2024 |
| Individual | 5.2% | 5.2% | 2024 | |
| Individual | 5.2% | 5.2% | 2024 | |
| Individual | 4.3% | 4.3% | 2024 | |
| Individual | 4.1% | 4.1% | 2024 | |
| Individual | 3.1% | 3.1% | 2024 | |
David James Kerr | Company | 2.9% | 2.9% | 2023 |
| Individual | 2.9% | 2.9% | 2024 | |
| Individual | 2.9% | 2.9% | 2024 | |
| Individual | 2.6% | 2.6% | 2024 | |
Marco Novelli | Company | 2.5% | 2.5% | 2023 |
James Kerr David | Company | 2.3% | 2.3% | 2024 |
Tekst Holding As | Company | 2.2% | 2.2% | 2024 |
Sls Capital 21 Gmbh | Company | 2.1% | 2.1% | 2024 |
Novelli Marco | Company | 2.0% | 2.0% | 2024 |
| Individual | 2.0% | 2.0% | 2024 | |
| Individual | 1.8% | 1.8% | 2024 | |
Inven2 As | Company | 1.8% | 1.8% | 2024 |
Widerberg Holding As | Company | 1.6% | 1.6% | 2024 |
John Robert Maddison | Company | 1.4% | 1.4% | 2024 |
| Individual | 1.4% | 1.4% | 2024 | |
| Individual | 1.1% | 1.1% | 2024 | |
| Individual | 1.1% | 1.1% | 2024 | |
Collin As | Company | 1.1% | 1.1% | 2024 |
| Individual | 1.1% | 1.1% | 2022 | |
| Individual | 1.1% | 1.1% | 2022 | |
Bleke Invest As | Company | 1.0% | 1.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DOMORE DIAGNOSTICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torbjørn Furuseth | Chief Executive Officer | 0 companies |
| Ketil Forsland Widerberg | Board of Directors | 0 companies |
| Sophie Grindstad | Board of Directors | 0 companies |
| Yngve Tvedt | Board of Directors | 0 companies |
| Ole Jesper Dahlberg | Board of Directors | 0 companies |
| Anders Tuv | Board of Directors | 0 companies |
| Øyvind Grotmol | Board of Directors | 0 companies |
| Ivar Kroghrud | Board of Directors | 0 companies |
| Tomas Nordheim Alme | Chairman | 0 companies |